U.S. drugmaker Mallinckrodt plans to file for bankruptcy protection

This post was originally published on this site

The company has entered into a restructuring agreement, which will help it to reduce its total debt by about $1.9 billion.

One of the biggest manufacturers of opioid drugs, the company had emerged out of bankruptcy in 2022.